DocGo Inc. (NASDAQ:DCGO) Stock Has Consensus Price Target of $2.38 According to Analysts

DocGo Inc. (NASDAQ:DCGO) has received an average rating of “Hold” from the six ratings firms that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have given a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $2.38.

A number of equities research analysts have commented on the company. Needham & Company LLC reissued a “buy” rating on shares of DocGo in a research note on Wednesday, September 30th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a research report on Monday, September 14th. Finally, Canaccord Genuity Group reiterated a “hold” rating and issued a $1.00 target price on shares of DocGo in a report on Tuesday, August 18th.

DocGo Price Performance

Shares of DCGO opened at $0.27 on Wednesday. The stock has a 50-day moving average of $0.36 and a 200-day moving average of $0.58. The company has a market cap of $26.71 million, a PE ratio of -0.14 and a beta of 0.97. DocGo has a one year low of $0.24 and a one year high of $1.19.

DocGo (NASDAQ:DCGO) last issued its earnings results on Monday, August 17th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). The company had revenue of $73.42 million during the quarter, compared to analyst estimates of $75.35 million. Analysts expect that DocGo will post -0.22 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Renaissance Technologies LLC lifted its position in DocGo by 167.1% in the 1st quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock valued at $950,000 after acquiring an additional 944,826 shares in the last quarter. S Squared Technology LLC acquired a new position in DocGo during the 2nd quarter valued at about $1,060,725. BlackRock Inc. acquired a new position in DocGo during the 2nd quarter valued at about $750,000. Empowered Funds LLC acquired a new position in DocGo during the 2nd quarter valued at about $79,000. Finally, Ieq Capital LLC bought a new stake in DocGo during the 2nd quarter worth approximately $126,000. 56.44% of the stock is owned by institutional investors.

DocGo Company Profile

DocGo Inc (NASDAQ:DCGO) is a healthcare services company that delivers medical care and related support outside traditional healthcare facilities. Its platform combines mobile medical services, technology and logistics to help healthcare providers, government agencies and other organizations improve access to care.

The company provides mobile health services that can include in-home and community-based clinical care, preventive services, diagnostic testing, vaccinations and care coordination.